Agili-C, a revolutionary cartilage regenerating technology from Israeli startup CartiHeal that could revolutionize treatment for cartilage damage and osteoarthritis, is preparing for a 2017 launch in the European market.
In addition to its original indication for patients with knee cartilage damaged by traumatic injury, the biological scaffold is now being tested for effectiveness in certain cases of osteoarthritis. This would widen its potential market significantly.
ISRAEL21c’s first report on CartiHeal’s revolutionary technology two years ago generated much interest from around the world – not surprising, considering that patients suffering from cartilage degeneration have few options.
Cartilage, the flexible soft tissue that cushions joints – especially in the knee – cannot self-heal once damaged, because it lacks blood vessels.
More...
ISRAEL21c was founded in 2001, in the wake of the Second Intifada, to broaden public understanding of Israel beyond typical portrayals in the mainstream media.
The organization’s founders – Israeli-American technology executives – understood the great power of the Internet and developed a first-of-its kind online product with global appeal and reach.
